Sep 20, 2023 · Atgam is a polyclonal antibody, or an immune globulin, given as an intravenous (IV, into a vein) infusion. Atgam is used to fight a type of white blood cell called a T-lymphocyte (also called a thymocyte or T-cell).

Anti-thymocyte globulin (ATG) is an infusion of horse or rabbit-derived antibodies against human T cells and their precursors (thymocytes), which is used in the prevention and treatment of acute rejection in organ transplantation and therapy of aplastic anemia due to …

ATGAM is indicated for the treatment of moderate to severe aplastic anemia in patients unsuitable for bone marrow transplantation [see Clinical Studies (14.2)].

ATGAM® (lymphocyte immune globulin, anti-thymocyte globulin [equine] sterile solution) This product information is intended only for residents of the United States. for Consumers: ATGAM - U.S. Medical Information Page - patient information, ways to contact Pfizer Medical & other resources for Healthcare professionals:

Aplastic anemia (moderate to severe) in patients unsuitable for bone marrow transplantation.

Dec 30, 2024 · What is Atgam (equine)? Lymphocyte immune globulin anti-thymocyte (also called equine anti-thymocyte immune globulin), is an immunosuppressant that lowers your body's immune system.

Dec 9, 2023 · Easy-to-read patient leaflet for Atgam. Includes indications, proper use, special instructions, precautions, and possible side effects.

ATGAM® (lymphocyte immune globulin, anti-thymocyte globulin [equine]) is a treatment for aplastic anemia and renal allograft rejection. Information for HCPs.

Dec 18, 2024 · Atgam (lymphocyte immune globulin, anti-thymocyte globulin [equine]) Sterile Solution is an immunosuppressant used to treat rejection of a kidney transplant as well as aplastic anemia. What Are Side Effects of Atgam? Atgam may cause serious side effects including: Get medical help right away, if you have any of the symptoms listed above.

ATGAM sterile solution is a lymphocyte-selective immunosuppressant as is demonstrated by its ability to reduce the number of circulating, thymus-dependent lymphocytes that form rosettes with sheep erythrocytes.